Source: Inpharma, Volume 1, Number 1403, 2003 , pp. 6-6(1)
Publisher: Adis International
Keywords: Children; Cost-analysis; Cost-minimisation; Dolasetron, therapeutic use; Ondansetron, therapeutic use; Vomiting, prevention
Document Type: Research article
Links for this article